Thanks a lot for the detailed answer… the dedicated capacities in case of Azad remind me of innovator pharma CDMOs where customer pays upfront in some cases, partially funding for their dedicated facilities… looking ahead to having such discussions thanks
Subscribe To Our Free Newsletter |